DFN-11 Injection in Episodic Migraine With or Without Aura
NCT02569853 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 268
Last updated 2018-07-26
Summary
Safety and Efficacy of DFN-11 in patients with episodic migraines with or without aura.
Conditions
- Episodic Migraine
Interventions
- DRUG
-
DFN-11
- OTHER
-
Placebo
Sponsors & Collaborators
-
Dr. Reddy's Laboratories Limited
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-21
- Primary Completion
- 2017-05-30
- Completion
- 2018-02-26
Countries
- United States
Study Locations
More Related Trials
-
An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)
NCT02856802 ·Status: COMPLETED ·Phase: PHASE2
-
Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches
NCT02472418 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY2951742 in Participants With Migraine
NCT01625988 ·Status: COMPLETED ·Phase: PHASE2
-
Can DFN-15 Terminate Migraine With Allodynia?
NCT03472378 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura
NCT00959751 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Study of MAP0004 in Adult Migraineurs
NCT00623636 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY3451838 in Participants With Migraine
NCT04498910 ·Status: COMPLETED ·Phase: PHASE2
-
Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.
NCT00358839 ·Status: COMPLETED ·Phase: NA
-
Endothelin-1 as a Potential Trigger of Migraine Aura
NCT02906085 ·Status: UNKNOWN ·Phase: NA
-
Study of NXN 188 for the Treatment of Migraine With Aura
NCT00920686 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
NCT02745392 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide
NCT07021859 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Sumatriptan With Naprosyn in Migraine With Aura
NCT00893594 ·Status: UNKNOWN ·Phase: NA
-
Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine
NCT02057315 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura
NCT00877838 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
NCT03488563 ·Status: COMPLETED ·Phase: PHASE2
-
A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines
NCT01813591 ·Status: COMPLETED ·Phase: PHASE2
-
Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)
NCT00687947 ·Status: COMPLETED ·Phase: NA
-
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
NCT00109083 ·Status: COMPLETED ·Phase: PHASE2
-
Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2
NCT00257985 ·Status: COMPLETED ·Phase: NA
-
Study in Participants With Acute Migraines Headaches
NCT00804973 ·Status: TERMINATED ·Phase: PHASE2
-
OnabotulinumtoxinA Injections in Chronic Migraine, Targeted to Sites of Pericranial Myofascial Pain
NCT03175263 ·Status: COMPLETED
-
A Study of LY2951742 in Healthy Volunteers
NCT01337596 ·Status: COMPLETED ·Phase: PHASE1
-
Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
NCT07061847 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating the Effectiveness of a Headache Management Program in Primary Care Settings
NCT05067725 ·Status: COMPLETED ·Phase: NA